$19.64
Price
$1.3B
Market Cap
—
P/E Ratio
-7.2
Forward P/E
$-3.11
EPS (TTM)
—
Dividend Yield
$335M
Cash
$3M
Total Debt
64M
Shares Out
$5.68
$21.00
52-Week Range
Institutional Ownership of Cullinan Therapeutics Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Cullinan Therapeutics Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q4 | |||||
| SELL | EXIT | — | — | $12.35 | |
| 2022-Q3 | |||||
| SELL | -72.0% | 429.6K | $6M | $13.42 | |
| 2021-Q4 | |||||
| SELL | -16.3% | 1.5M | $23M | $20.96 | |
| 2021-Q1 | |||||
| BUY | NEW | 1.8M | $72M | $39.68 | |
Insider Trading for Cullinan Therapeutics Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.